Global Opioid Withdrawal Syndrome (OWS) Market- (By Therapy- Lucemyra (Lofexidine), Methadone, Buprenorphine, Naltrexone and Others (Britlofex, Masimo Bridge, etc.); and By Country) - Industry Dynamics, Market Size and Opportunity Forecast, 2030
- Published Date: Apr-2022 | Format:
![pdf]()
![powerpoint]()
![excel]()
| Report ID: AA0422201 | Delivery: 2 to 4 Hours
| Report ID: AA0422201 | Delivery: 2 to 4 Hours Table 1:Market Overview: 7MM Opioid Withdrawal Syndrome Market Size (US$ Mn), By Country, 2018-2030
Table 2:7MM Opioid Withdrawal Syndrome Market Size (US$ Mn), By Therapy, 2018-2030
Table 3:US Opioid Withdrawal Syndrome Market Size (US Mn), By Therapy, 2018-2030
Table 4:UK Opioid Withdrawal Syndrome Market Size (US Mn), By Therapy, 2018-2030
Table 5:Germany Opioid Withdrawal Syndrome Market Size (US Mn), By Therapy, 2018-2030
Table 6:France Opioid Withdrawal Syndrome Market Size (US Mn), By Therapy, 2018-2030
Table 7:Italy Opioid Withdrawal Syndrome Market Size (US Mn), By Therapy, 2018-2030
Table 8:Spain Opioid Withdrawal Syndrome Market Size (US Mn), By Therapy, 2018-2030
Table 9:Japan Opioid Withdrawal Syndrome Market Size (US Mn), By Therapy, 2018-2030
Figure1:Executive Summary: Opioid Prescription Rate per 100 persons (in US$)
Figure2:Executive Summary: Global Opioid Withdrawal Syndrome (OWS) Market Size, By Value, 2021-2030
Figure3:Executive Summary: 7MM Opioid Withdrawal Syndrome Market Size, By Therapy, 2021
Figure4:7MM Opioid Withdrawal Syndrome Market Share (%), by Country, 2021
Figure5:7MM Opioid Withdrawal Syndrome Market Share (%), by Country, 2030
Figure6:Epidemiology and Patient Population: Total Prevalent Cases of OWS in the 7MM, 2021
Figure7:Diagnosed and Treatable Cases of OWS in the 7MM: Diagnosed cases of OWS in 7MM, 2021
Figure8:Diagnosed and Treatable Cases of OWS in the 7MM: Treatable cases of OWS in 7MM, 2021
Figure9:United States Epidemiology: Total Prevalent Cases of OWS in the United States
Figure10:United States Epidemiology: Total diagnosed OWS cases in the United States (2015-2019)
Figure11:United States Epidemiology: Total Treatable OWS cases in the United States (2015-2019)
Figure12:Germany Epidemiology: Total Prevalent Cases of OWS in the Germany
Figure13:Germany Epidemiology: Total diagnosed OWS cases in Germany (2015-2019)
Figure14:Germany Epidemiology: Total Treatable OWS cases in Germany (2015-2019)
Figure15:United Kingdom Epidemiology: Total Prevalent Cases of OWS in the UK
Figure16:United Kingdom Epidemiology: Total diagnosed OWS cases in United Kingdom (2015-2019)
Figure17:United Kingdom Epidemiology: Total Treatable OWS cases in United Kingdom (2015-2019)
Figure18:France Epidemiology: Total Prevalent Cases of OWS in the France
Figure19:France Epidemiology: Total diagnosed OWS cases in France (2015-2019)
Figure20:France Epidemiology: Total Treatable OWS cases in France (2015-2019)
Figure21:Spain Epidemiology: Total Prevalent Cases of OWS in the Spain
Figure22:Spain Epidemiology: Total diagnosed OWS cases in Spain (2015-2019)
Figure23:Spain Epidemiology: Total Treatable OWS cases in Spain (2015-2019)
Figure24:Italy Epidemiology: Total Prevalent Cases of OWS in the Italy
Figure25:Italy Epidemiology: Total diagnosed OWS cases in Italy (2015-2019)
Figure26:Italy Epidemiology: Total Treatable OWS cases in Italy (2015-2019)
Figure27:Japan Epidemiology: Total Prevalent Cases of OWS in the Japan
Figure28:Japan Epidemiology: Total diagnosed OWS cases in Japan (2015-2019)
Figure29:Japan Epidemiology: Total Treatable OWS cases in Japan (2015-2019)
Figure30:7MM Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2021
Figure31:7MM Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2030
Figure32:US Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2021
Figure33:US Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2030
Figure34:UK Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2021
Figure35:UK Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2030
Figure36:Germany Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2021
Figure37:Germany Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2030
Figure38:France Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2021
Figure39:France Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2030
Figure40:Italy Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2021
Figure41:Italy Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2030
Figure42:Spain Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2021
Figure43:Spain Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2030
Figure44:Japan Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2021
Figure45:Japan Opioid Withdrawal Syndrome Market Share (%), by Therapy, 2030
Figure46:Market Dynamics- Drivers: Death Due to Drug Use
Choose License Type
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
